Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

Summary

This study is being done to: * Test the safety of EP-100 and see what effect (good and bad) it has on the patient and their cancer; * Find the highest dose of EP-100 that can be given without causing bad side effects; * Examine how much EP-100 is in the blood at certain times after it is given and how quickly the body gets rid of it; * Observe whether there is any effect of EP-100 on the size and activity of cancer in the patient's body.

Timeline

Start

2009-07

Primary completion

2012-03

Completion

2012-03

Drugs

Indications